Table 4. P-values for symptom present and absent comparisons within pre-vaccinated or post-vaccinated titers and ACE2 IC50.
NCP | NTD | RBD1 | RBD2 | ST4 | ACE2 IC50 | |
---|---|---|---|---|---|---|
Pre-vaccinated symptom present and absent | ||||||
Fever | 0.013* | 0.0065* | 0.0022* | 0.0036* | 0.002* | 0.0072* |
Cough | 0.0016* | 0.0012* | 0.0024* | 0.00023* | 0.00093* | 0.00055* |
Anosmia/Ageusia | 0.0001* | 0.00017* | 0.00012* | 0.000092* | 0.0001* | 0.00065* |
Post-vaccinated symptom present and absent | ||||||
Fever | 0.72 | 0.80 | 0.92 | 0.44 | 0.96 | 0.68 |
Cough | 0.56 | 0.94 | 0.70 | 0.94 | 0.70 | 0.49 |
Anosmia/Ageusia | 0.35 | 0.27 | 0.94 | 0.46 | 0.56 | 0.94 |